Evidence map›Paper›PMID 36845311›Full record

ArticleJournal of clinical and translational science2023

The CTSA Diversity, Equity, Inclusion, and Accessibility (DEIA) Task Force's recommendations for the CTSA program consortium.

Lori Carter-Edwards, Maia Hightower, Vanessa Schick, Tung Nguyen, Bertha Hidalgo, Lisa Cacari Stone, Rebecca Laird, Deborah Ossip, Mercedes Rubio, Sanae ElShourbagy Ferreira and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical and translational science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Lori Carter-EdwardsThe North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Maia HightowerUtah Clinical and Translational Science Institute, University of Utah, Salt Lake City, UT, USA.
Vanessa SchickCenter for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
Tung NguyenUniversity of California San Francisco Clinical and Translational Science Institute, San Francisco, CA, USA.
Bertha HidalgoCenter for Clinical and Translational Science, The University of Alabama at Birmingham, Birmingham, AL, USA.
Lisa Cacari StoneUniversity of New Mexico Clinical and Translational Sciences Center, Albuquerque, NM, USA.
Rebecca LairdCenter for Leading Innovation and Collaboration (CLIC), University of Rochester Clinical Translational Science Institute, Rochester, NY, USA.ORCID https://orcid.org/0000-0001-7193-4976
Deborah OssipCenter for Leading Innovation and Collaboration (CLIC), University of Rochester Clinical Translational Science Institute, Rochester, NY, USA.
Mercedes RubioDivision of Training, Workforce Development, and Diversity, National Institute of General Medicical Sciences, National Institutes of Health, Bethesda, MD, USA.ORCID https://orcid.org/0000-0002-3979-7171
Sanae ElShourbagy FerreiraClinical and Translational Science Awards Program Branch, National Center for Advancing Translational Science, National Institutes of Health, Bethesda, MD, USA.
Olveen CarrasquilloUniversity of Miami Clinical and Translational Science Institute, Miami, FL, USA.
National Institutes of Health · USUniversity of Rochester · USUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USUniversity of Miami · USUniversity of New Mexico · USUniversity of North Carolina at Chapel Hill · USUniversity of Utah · US

Funding

Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
Convalescent Plasma to Limit Coronavirus Associated ComplicationsUL1TR003167 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARP, DANIEL D, MCPHERSON, DAVID D · 2019 to 2023
$45.3M
UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patientsUL1TR002556 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, KIM, MIMI Y · 2018 to 2022
$26.7M
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Miami Clinical and Translational Science InstituteUL1TR002736 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CARRASQUILLO, OLVEEN, KOBETZ, ERIN N · 2018 to 2022
$23.2M
CTSA Coordinating Center for Leading Innovation and Collaboration (CLIC)U24TR002260 · NCATS · UNIVERSITY OF ROCHESTER · PI OSSIP, DEBORAH J, ZAND, MARTIN S · 2017 to 2021
$19.0M
Epigenetic biomarkers of preeclampsia risk among mothers with chronic hypertensionR01HL155127 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HIDALGO, BERTHA, TITA, ALAN THEVENET N. · 2022 to 2025
$2.6M
NCATS NIH HHS U24 TR002260NCATS NIH HHS UL1 TR001449NCATS NIH HHS UL1 TR001872NCATS NIH HHS UL1 TR002489NCATS NIH HHS UL1 TR002538NCATS NIH HHS UL1 TR002556NCATS NIH HHS UL1 TR002736NCATS NIH HHS UL1 TR003167NHLBI NIH HHS R01 HL155127
6 · The paper itself

Abstract

The Clinical and Translational Science Award (CTSA) Program recognizes that advancing diversity, equity, inclusion, and accessibility (DEIA) requires moving beyond statements of commitment to transformative actions. In 2021, the CTSA Program created a Task Force (TF) to initiate work in support of structural and transformational initiatives that advance DEIA for the consortium and its individual hubs. We describe the process of forming the expertise-driven (DEIA) TF and our activities to date. We 1) developed and adopted the DEIA Learning Systems Framework to guide our approach; 2) defined a set of recommendations across four focus areas (Institutional; Programmatic; Community-Centered; and Social, Cultural, Environmental); and 3) designed and disseminated a survey to capture the CTSA Program's baseline demographic, community, infrastructural, and leadership diversity. The CTSA Consortium also elevated the TF to a standing Committee to extend our understanding, development, and implementation of DEIA approaches to translational and clinical science. These initial steps provide a foundation for collectively fostering environment that support DEIA across the research continuum.

Indexed as

accountability frameworkand accountability (DEIA)Clinical and Translational Science Award (CTSA)consortiumdiversityequityinclusionlearning system frameworkrecommendationstask forceworkforce

Identifiers

PMID36845311
PMCPMC9947599
OpenAlexW4311377634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.